SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?

To: PawPr who wrote (522)1/29/1998 9:18:00 AM
From: FNS  Read Replies (1) | Respond to of 965
 
Thanks Bruce and Todd: <<....can be used to treat regular and low-risk angioplasty patients, as well as patients with refractory unstable angina who are scheduled for surgery within 24 hours, according to Bill Newbould, a Centocor spokesman.>>

Is CNTO still trying to get approval for more broad unstable angina?

Good luck all.

FNS



To: PawPr who wrote (522)1/30/1998 6:43:00 PM
From: Pancho Villa  Read Replies (2) | Respond to of 965
 
Bruce: What do you think about SBH giving up merger talks with AHP? I guess SBH may be concerned about Redux product liability. Not the type of situation you willingly walk into. I continue short IPIC.

biz.yahoo.com

Pancho


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News